Biofrontera Inc. Costs and Expenses, Related Party
Biofrontera Inc. (BFRI) reported Costs and Expenses, Related Party of $152.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpensesRelatedParty · last filed 2024-03-15
- Biofrontera Inc. costs and expenses, related party for the quarter ending 2023-12-31 was -$41.00K, a 133.88% decline year-over-year.
- Biofrontera Inc. costs and expenses, related party for the quarter ending 2023-09-30 was $74.00K, a 56.73% decline year-over-year.
- Biofrontera Inc. costs and expenses, related party for the quarter ending 2023-06-30 was $92.00K, a 73.41% decline year-over-year.
- Biofrontera Inc. costs and expenses, related party for the quarter ending 2023-03-31 was $27.00K, a 71.58% decline year-over-year.
- Biofrontera Inc. costs and expenses, related party for fiscal 2023 was $152.00K, a 79.26% decline from fiscal 2022.
- Biofrontera Inc. costs and expenses, related party for fiscal 2022 was $733.00K, a 5.16% increase from fiscal 2021.
- Biofrontera Inc. costs and expenses, related party for fiscal 2021 was $697.00K, a 69.59% increase from fiscal 2020.
- Biofrontera Inc. costs and expenses, related party for fiscal 2020 was $411.00K.
| Period end | Costs and Expenses, Related Party 3 month | Costs and Expenses, Related Party 6 month | Costs and Expenses, Related Party 9 month | Costs and Expenses, Related Party 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $33.00K derived: sum of 2 quarters · filed 2024-03-15 | $125.00K derived: sum of 3 quarters · filed 2024-03-15 | $152.00K 10-K · filed 2024-03-15 |
| 2023-09-30 | $74.00K 10-Q · filed 2023-11-09 | $166.00K derived: sum of 2 quarters · filed 2023-11-09 | $193.00K 10-Q · filed 2023-11-09 | $314.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2023-06-30 | $92.00K 10-Q · filed 2023-08-11 | $119.00K 10-Q · filed 2023-08-11 | $240.00K derived: sum of 3 quarters · filed 2024-03-15 | $411.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2023-03-31 | $27.00K 10-Q · filed 2023-05-12 | $148.00K derived: sum of 2 quarters · filed 2024-03-15 | $319.00K derived: sum of 3 quarters · filed 2024-03-15 | $665.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $292.00K derived: sum of 2 quarters · filed 2024-03-15 | $638.00K derived: sum of 3 quarters · filed 2024-03-15 | $733.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $171.00K 10-Q · filed 2023-11-09 | $517.00K derived: sum of 2 quarters · filed 2023-11-09 | $612.00K 10-Q · filed 2023-11-09 | $789.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $346.00K 10-Q · filed 2023-08-11 | $441.00K 10-Q · filed 2023-08-11 | $618.00K derived: sum of 3 quarters · filed 2023-08-11 | $778.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $95.00K 10-Q · filed 2023-05-12 | $272.00K derived: sum of 2 quarters · filed 2023-05-12 | $432.00K derived: sum of 3 quarters · filed 2023-05-12 | $628.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $337.00K derived: sum of 2 quarters · filed 2023-03-13 | $533.00K derived: sum of 3 quarters · filed 2023-03-13 | $697.00K 10-K · filed 2023-03-13 |
| 2021-09-30 | $160.00K 10-Q · filed 2022-11-14 | $356.00K derived: sum of 2 quarters · filed 2022-11-14 | $520.00K 10-Q · filed 2022-11-14 | $534.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $196.00K 10-Q · filed 2022-08-12 | $360.00K 10-Q · filed 2022-08-12 | $374.00K derived: sum of 3 quarters · filed 2022-08-12 | $485.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $164.00K 10-Q · filed 2022-05-13 | $178.00K derived: sum of 2 quarters · filed 2022-05-13 | $289.00K derived: sum of 3 quarters · filed 2022-05-13 | |
| 2020-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $125.00K derived: sum of 2 quarters · filed 2022-04-11 | $411.00K 10-K · filed 2022-04-11 | |
| 2020-09-30 | $111.00K 10-Q · filed 2021-11-30 | $397.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |